Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Human Stem Cell Graft Stimulates Neuron Regeneration in Rats with Spinal Injury

By BiotechDaily International staff writers
Posted on 06 Jun 2013
Print article
Image: A three-dimensional, reconstructed magnetic resonance image (upper) shows a cavity caused by a spinal injury nearly filled with grafted neural stem cells, colored green. The lower image depicts neuronal outgrowth from transplanted human neurons (green) and development of putative contacts (yellow dots) with host neurons (blue) (Photo courtesy of the University of California, San Diego School of Medicine).
Image: A three-dimensional, reconstructed magnetic resonance image (upper) shows a cavity caused by a spinal injury nearly filled with grafted neural stem cells, colored green. The lower image depicts neuronal outgrowth from transplanted human neurons (green) and development of putative contacts (yellow dots) with host neurons (blue) (Photo courtesy of the University of California, San Diego School of Medicine).
Image: Senior author Dr. Martin Marsala (Photo courtesy of the University of California, San Diego School of Medicine).
Image: Senior author Dr. Martin Marsala (Photo courtesy of the University of California, San Diego School of Medicine).
Human neural stem cells injected into rats with acute spinal cord injury generated connections between the injected stem cells and surviving host neurons, which stimulated host neuron regeneration and partially replaced the neurons destroyed by the injury.

Investigators at the University of California, San Diego School of Medicine (USA) worked with a model system comprising three-month-old female Sprague-Dawley rats with induced spinal compression injury. Three days postinjury, the animals were randomized and some received intraspinal injections of either human fetal spinal cord-derived neural stem cells (HSSC) or media-only, or did not receive an injection. All animals were immunosuppressed from the day of cell grafting and survived for eight weeks.

Results published in the May 28, 2013, online edition of the journal Stem Cell Research & Therapy revealed that the intraspinal grafting of HSSC in the injured animals led to a progressive and significant improvement in lower extremity paw placement, amelioration of spasticity, and normalization in thermal and tactile pain/escape thresholds at eight weeks post-grafting. Magnetic resonance imaging volume reconstruction and immunofluorescence analysis of grafted cell survival showed near complete injury-cavity-filling by grafted cells and development of putative synapses between grafted and host neurons.


Print article

Channels

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.